BIOMAT Database Logo BIOMAT Database Logo

[Efficacy and tolerability of 2 presentations of eyedrops combining carteolol 2% and pilocarpine 2% in primary open-angle glaucoma and simple ocular hypertension]. 1995

D Sirbat, and J F Charlin, and H Cohn, and J C Dascotte, and J L George, and P Lesure, and M Massin, and G Massin, and J F Maurin, and J P Renard
CHU de Rouen.

OBJECTIVE The aim of the study was to compare 2 combinations of eye drops containing 2% carteolol and 2% pilocarpine: LCM 1010: ready to use eye drops CBS 341A: eye drops to be reconstituted (freeze-dried powder + solvent). METHODS Ninety-seven patients with primary open angle glaucoma or simple ocular hypertension were included in a randomized, double-blind multicentric study comparing 2 parallel groups of treatment. Intra-ocular pressure was greater than 21 mmHg with beta-blocker alone. One instillation of 2% carteolol-2% pilocarpine combination was given twice a day for one month. Before and after this treatment, intra-ocular pressure was measured at 9 am (12 hours after evening instillation) and at 11 am (2 hours after morning instillation). RESULTS Both treatments reduced intra-ocular pressure by a comparable amount and there was no significant difference between groups at either measure: at 9 am: 2.11 +/- 2.39 mmHg (mean +/- SD) for LCM 1010 1.79 +/- 1.73 mmHg for CBS 341 A p = 0.25 at 11 am: 3.75 +/- 3.83 mmHg for LCM 1010 3.40 +/- 1.69 mmHg for CBS 341 A p = 0.42. Both eye drops were generally well tolerated. CONCLUSIONS Efficacy and safety of ready to use eye drops 2% carteolol-2% pilocarpine combination proved to be comparable to that of eye drops to be reconstituted in the treatment of ocular hypertension poorly controlled by beta-blocker eye drops alone.

UI MeSH Term Description Entries
D008297 Male Males
D009798 Ocular Hypertension A condition in which the intraocular pressure is elevated above normal and which may lead to glaucoma. Glaucoma, Suspect,Hypertension, Ocular,Glaucomas, Suspect,Hypertensions, Ocular,Ocular Hypertensions,Suspect Glaucoma,Suspect Glaucomas
D009883 Ophthalmic Solutions Sterile solutions that are intended for instillation into the eye. It does not include solutions for cleaning eyeglasses or CONTACT LENS SOLUTIONS. Eye Drop,Eyedrop,Eyedrops,Ophthalmic Solution,Eye Drops,Drop, Eye,Drops, Eye,Solution, Ophthalmic,Solutions, Ophthalmic
D010862 Pilocarpine A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma. Isopilocarpine,Isoptocarpine,Ocusert,Pilocarpine Hydrochloride,Pilocarpine Mononitrate, (3S-cis)-Isomer,Pilocarpine Nitrate,Pilocarpine, Monohydrochloride, (3S-cis)-Isomer,Salagen,Hydrochloride, Pilocarpine,Nitrate, Pilocarpine
D002354 Carteolol A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent. Carteolol Hydrochloride,Carteolol Monohydrochloride,OPC-1085,Hydrochloride, Carteolol,Monohydrochloride, Carteolol,OPC 1085,OPC1085
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005260 Female Females
D005902 Glaucoma, Open-Angle Glaucoma in which the angle of the anterior chamber is open and the trabecular meshwork does not encroach on the base of the iris. Glaucoma Simplex,Glaucoma, Pigmentary,Glaucoma, Simple,Open-Angle Glaucoma,Chronic Primary Open Angle Glaucoma,Glaucoma, Compensated,Glaucoma, Compensative,Glaucoma, Open Angle,Glaucoma, Primary Open Angle,Glaucoma, Secondary Open Angle,Primary Open Angle Glaucoma,Secondary Open Angle Glaucoma,Compensated Glaucoma,Compensative Glaucoma,Open Angle Glaucoma,Open Angle Glaucomas,Open-Angle Glaucomas,Pigmentary Glaucoma,Simple Glaucoma,Simplex, Glaucoma,Simplices, Glaucoma
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D Sirbat, and J F Charlin, and H Cohn, and J C Dascotte, and J L George, and P Lesure, and M Massin, and G Massin, and J F Maurin, and J P Renard
[Pilocarpine, carbachol and carteolol on open-angle glaucoma and ocular hypertension (author's transl)].
January 1981, Nippon Ganka Gakkai zasshi,
D Sirbat, and J F Charlin, and H Cohn, and J C Dascotte, and J L George, and P Lesure, and M Massin, and G Massin, and J F Maurin, and J P Renard
Pilocarpine medication in open-angle glaucoma. A study using pilocarpine eyedrops and an ocular therapeutic system.
February 1979, Acta ophthalmologica,
D Sirbat, and J F Charlin, and H Cohn, and J C Dascotte, and J L George, and P Lesure, and M Massin, and G Massin, and J F Maurin, and J P Renard
Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension.
December 2014, The Annals of pharmacotherapy,
D Sirbat, and J F Charlin, and H Cohn, and J C Dascotte, and J L George, and P Lesure, and M Massin, and G Massin, and J F Maurin, and J P Renard
[Primary open-angle glaucoma. Effects of an eyedrop combining timolol and pilocarpine on the ocular pressure].
January 1990, Journal francais d'ophtalmologie,
D Sirbat, and J F Charlin, and H Cohn, and J C Dascotte, and J L George, and P Lesure, and M Massin, and G Massin, and J F Maurin, and J P Renard
A comparison of the efficacy of various metipranolol-pilocarpine combinations in patients with ocular hypertension and primary open-angle glaucoma.
January 1994, Journal of ocular pharmacology,
D Sirbat, and J F Charlin, and H Cohn, and J C Dascotte, and J L George, and P Lesure, and M Massin, and G Massin, and J F Maurin, and J P Renard
Management of ocular hypertension and primary open angle glaucoma.
January 2000, Clinical & experimental optometry,
D Sirbat, and J F Charlin, and H Cohn, and J C Dascotte, and J L George, and P Lesure, and M Massin, and G Massin, and J F Maurin, and J P Renard
Short-term ocular tolerability of dorzolamide 2% and brinzolamide 1% vs placebo in primary open-angle glaucoma and ocular hypertension subjects.
September 2004, Eye (London, England),
D Sirbat, and J F Charlin, and H Cohn, and J C Dascotte, and J L George, and P Lesure, and M Massin, and G Massin, and J F Maurin, and J P Renard
Randomized, Controlled, Phase 3 Trials of Carteolol/Latanoprost Fixed Combination in Primary Open-Angle Glaucoma or Ocular Hypertension.
November 2016, American journal of ophthalmology,
D Sirbat, and J F Charlin, and H Cohn, and J C Dascotte, and J L George, and P Lesure, and M Massin, and G Massin, and J F Maurin, and J P Renard
Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
December 2008, Acta ophthalmologica,
D Sirbat, and J F Charlin, and H Cohn, and J C Dascotte, and J L George, and P Lesure, and M Massin, and G Massin, and J F Maurin, and J P Renard
A Randomized, Phase 2 Study of 24-h Efficacy and Tolerability of Netarsudil in Ocular Hypertension and Open-Angle Glaucoma.
March 2021, Ophthalmology and therapy,
Copied contents to your clipboard!